 |
|
ORIGINAL ARTICLE |
|
| Year : 2011 | Volume
: 6
| Issue : 2 | Page : 91-95 |
|
| Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection |
|
|
Payam Tabarsi1, Ahmadreza Moradi2, Majid Marjani1, Parvaneh Baghaei1, Seyed Mohammadreza Hashemian3, Seyed Alireza Nadji3, Atefeh Fakharian4, Davood Mansouri4, Mohammadreza Masjedi5, Aliakbar Velayati6
1 Virology Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Virology Research Center; Nursing and Respiratory Health Management Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Nursing and Respiratory Health Management Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Chronic Respiratory Disease Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Pediatric Respiratory Disease Research Center, NRITLD, Masih-Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| Date of Submission | 11-Oct-2010 |
| Date of Acceptance | 11-Jan-2011 |
| Date of Web Publication | 28-Mar-2011 |
Correspondence Address:
Ahmadreza Moradi
Virology Research Center, NRITLD, Masih-Daneshvari Hospital, Darabad, Shahid Bahonar Ave., Tehran
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.78429
|
|
 Abstract | | |
Background : In preparation for pandemic H1N1 or H1N1 influenza (H1N1) it is necessary to identify factors associated with mortality of patients with H1N1 and hospital admissions to intensive care unit (ICU) of patients diagnosed in 2009 with H1N1.
Objectives : To describe the clinical and epidemiological features associated with 2009 H1N1 mortality and ICU patient admissions to Masih Daneshvari Teaching Hospital, Iran.
Methods : A retrospective cross-sectional study was conducted among patients with mortality and admissions to ICU with confirmed H1N1. Demographic, clinical, laboratory, radiological findings, and epidemiologic data were abstracted from medical records, using a standardized datasheet.
Results : From June through December 2009, 20 out of the 46 confirmed hospitalized patients with confirmed H1N1 were admitted to the ICU and 7 (15%) died. Among various variables, opium inhalation (P = 0.01), having productive cough, hemoptysis, chest pain, confusion, and loss of consciousness were significantly related to ICU admission (P < 0.05). Pleural effusion (P = 0.006), elevated liver enzymes, as well as CPK and LDH level were significantly relevant to ICU admission (P < 0.05). Delayed antiviral treatment was more common among patients who died and the elderly.
Discussion : Patients who were admitted to ICU with confirmed H1N1 included the following risk factors: delayed initiation of antiviral therapy, history of opium inhalation and symptoms including; productive cough, hemoptysis, chest pain, confusion, and loss of consciousness. The mortality rate in the study population was high but compares favorably with other recent published studies.
Keywords: Hospital mortality, influenza a virus H1N1 subtype, intensive care units, risk factors
How to cite this article:
Tabarsi P, Moradi A, Marjani M, Baghaei P, Hashemian SM, Nadji SA, Fakharian A, Mansouri D, Masjedi M, Velayati A. Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection. Ann Thorac Med 2011;6:91-5 |
How to cite this URL:
Tabarsi P, Moradi A, Marjani M, Baghaei P, Hashemian SM, Nadji SA, Fakharian A, Mansouri D, Masjedi M, Velayati A. Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection. Ann Thorac Med [serial online] 2011 [cited 2023 Mar 21];6:91-5. Available from: https://www.thoracicmedicine.org/text.asp?2011/6/2/91/78429 |
On 11 June 2009, the World Health Organization formally confirmed the first pandemic of influenza for 40 years. [1] A novel influenza A (H1N1) virus, which is a genetic resentment of four influenza A viruses (i.e., swine influenza, human seasonal influenza, avian influenza, and Eurasian swine), began to cause illness in Iran three months after it first emerged in Mexico in March 2009. [2],[3],[4]
In the context of 2009 pandemic, clinicians were uncertain regarding the clinical and laboratory findings of H1N1 pneumonias (H1N1). Therefore, identifying factors associated with the death or intensive care unit (ICU) admission of hospitalized patients with 2009 H1N1 is critical in preparation for the potential waves of pandemic H1N1 influenza. Current reports have suggested in addition to many of the previously known risk factors for complications of seasonal influenza, underlying co-morbidities and delayed initiation of antiviral therapy as risk factors for severe disease. [5],[6],[7],[8]
Although during the 2009 pandemic outbreak a large number of individuals who referred to the Emergency Department (ED) with influenza-like illnesses (ILIs) were admitted to regular wards, few patients were admitted to the ICU.
Objective
To describe the clinical and epidemiological features associated with ICU admission and death of hospitalized patients with 2009 H1N1.
| Methods | |  |
A retrospective cross-sectional study was conducted among patients who were hospitalized with confirmed 2009 H1N1 virus infection. Demographic, clinical, laboratory data included; complete blood count, liver function test, erythrocyte sedimentation rate (ESR), creatinine blood level (Cr), creatine phosphokinase blood level (CPK), lactate dehydrogenase blood level (LDH), O 2 saturation, sputum culture for bacteria and blood culture, radiological findings, and epidemiologic data were extracted from medical records, using a standardized datasheet. The comparison was done between ICU admitted patients and non-ICU patients. Clinical and laboratory data were compared between patients who died and those who survived.
Setting
Masih Daneshvari Teaching Hospital is the largest tertiary health care center for patients with respiratory diseases in Tehran, Iran. During the outbreak of 2009 pandemic, this hospital was a reference center for H1N1 cases in Tehran, with the aim of controlling the pandemic. The study was conducted during June through December 2009. All admitted patients with laboratory confirmed H1N1 influenza were included in the study.
Laboratory confirmation
Respiratory tract specimens (including; nasopharyngeal aspirates/swabs, and endotracheal/bronchoscopic aspirates) were properly treated at the virology laboratory immediately. Nucleic acid was extracted with QIAamp® Viral RNA Mini Kit (QIAGEN GmbH, Germany) and Invisorb® Spin Virus RNA Mini Kit (Invitek, Germany). cDNA was synthesized by RevertAid TM H Minus First Strand cDNA synthesis kit (Fermentas LIFE SCIENCES) according to the manufacturer's instruction. The presence of the pandemic H1N1 2009 infection was confirmed by real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR), run on BioRad CFX96 TM real time PCR machine (USA), according to the protocol developed by the Center for Disease Control (CDC), USA. [9]
Statistical analysis
Statistical analyses were performed using the SPSS software. The two-sided χ2 test was used for comparison of categorical variables, with Fisher's correction when needed. The t-test was used for comparison of the continuous variables. To analyze for the ICU admission and mortality, we used logistic regression. A two-tailed P-value of less than 0.05 was considered statistically significant. To determine the independent risk factors, a multivariate logistic regression analysis was performed for the factors which had P < 0.2 in univariate analysis.
Ethics
The study was approved by the institutional ethics committee.
| Results | | |
From June through December 2009, 125 of 656 patients who were referred to the hospital with influenza-like illnesses (ILIs) were admitted to regular wards. A retrospective review of 46 hospitalized patients with laboratory confirmed 2009 H1N1 virus infection was carried out.
Of the 46 patients studied, 20 (43%) were admitted to the ICU and 7 (15%) died. The mean age of patients was 36.9 ± 12.92 years (range: 15-66, median: 32) and only one patient was over 65 years old. The male-to-female ratio was 1.3:1 (26:20). Out the total of 46, 7 patients (15.2%) were cigarette smokers and 10 (21.7%) were drug abusers (Including; opium inhalation in eight patients and intravenous drug abuse (IVDA) in two of them). History of drug abuse was more common among ICU admitted patients and the opium inhalation rate was significantly common in these patients (P = 0.01) [Table 1]. | Table 1: Baseline characteristics of hospitalized patients with laboratory-confirmed 2009 pandemic (H1N1) influenza
Click here to view |
Of the 46 patients, 21 (45.7%) had at least one underlying medical condition and the most common coexisting condition was asthma with the incidence of 8 (17.4 %) [Table 2]. | Table 2: Co-existing conditions, para clinical data, and treatment regimen of hospitalized patients with laboratory-confirmed 2009 pandemic (H1N1) influenza
Click here to view |
The clinical signs and symptoms included productive cough, hemoptysis, chest pain, confusion, and loss of consciousness (P < 0.05) [Table 1].
Blood culture and sputum culture were performed for all admitted patients. Positive sputum and/or blood culture was more common in ICU admitted patients. All patients underwent chest radiography on admission and 74% (34/46) had abnormal chest radiograph. Bilateral alveolar opacity was the most common pattern (32.6%). The following findings were relevant to ICU patients: pleural effusion (P = 0.006), laboratory test results indicated higher prevalence of leukopenia, thrombocytopenia and increased level of Cr, elevated liver enzymes, CPK and LDH level (P < 0.05), low O 2 saturation level (P < 0.001) [Table 2].
In patients who died, antiviral treatment was initiated at a mean time of 7.42 ± 4.07 days after the onset of illness which was longer than that of the ICU patients (6.42 ± 3.54) and other patients who survived (5.29 ± 3.68). Mean ICU stay duration was longer among patients who died (21.71 ± 19.05 vs. 10.5 ± 5.7, P = 0.07). Mortality findings included: elderly patients (mean age: 43 ± 14.29 vs. 34.64 ± 12.46), higher levels of ESR, and long-term mechanical ventilation (mean ventilation day: 15.14 vs. 1.08, P = 0.006).
Out of the total number of 46, 15 were co-infected with seasonal influenza A virus, including 2 out of 7 of dead patients (P > 0.05). Six out of 15 co-infected patients needed ICU admission during their hospitalization. To analyze for the ICU admission and mortality, a multivariate logistic regression analysis was performed and revealed no significant difference between study groups.
| Discussion | | |
During the spring of 2009, pandemic H1N1 influenza virus caused human infection and acute respiratory illness in Mexico. [3] Rates of hospitalization and death have varied widely according to country. [10] In the United States, approximately 9-31% of hospitalized patients with pandemic influenza were admitted to the ICU, with a mortality rate of 14-46%. [11],[12],[13],[14] As there were limited data about developing countries, we evaluated factors associated with ICU admission and in-patient mortality in a tertiary care center in Iran.
Although some underlying conditions are known as risk factors for complications from 2009 H1N1 virus infection, [15] we did not find any significant difference between the ICU patient admissions and other patients. More than half of patients (54%) with 2009 H1N1 virus infections who were hospitalized had no reported coexisting medical conditions. This finding is compatible with other studies around the globe. [11],[13],[14],[16] Only one survived ICU patient was HIV-1 positive. The principal clinical symptoms leading to ICU admission were chest pain, hemoptysis, purulent sputum, altered mental status, loss of consciousness, and severe hypoxemia. These findings are similar to the finding of other studies. [13],[14]
Like previous studies [3],[12],[14] laboratory findings include normal or low leukocyte counts. Elevations in levels of serum aminotransferases, LDH, CPK, Cr, and ESR were documented in ICU patients. The presence of thrombocytopenia was a common finding, but there was no significant difference between the two groups.
Radiographic findings in chest X-ray commonly included bilateral ground-glass opacities, patchy infiltrates, and alveolar consolidation. Among various radiographic findings, pleural effusions were considered as an ICU admission risk factor.
Bacterial pneumonia was not a common finding in either patient population. Although usually it is caused by Staphylococcus aureus (often methicillin-resistant), Streptococcus pneumoniae, and S. pyogenes, [13],[14],[17] our findings indicated Acinetobacter, Pseudomonas, and Coagulase negative staphylococci in a minority of patients.
The burden and nature of the disease in developing countries is still incompletely understood. [18] The study has some limitations, including retrospective design, small study population, and being conducted in a tertiary referral center. Due to limitations listed above, some important information, like the history of seasonal flu vaccination, was missing.
The mortality rate in the study population was high but compared favorably with other published studies. Severe pandemic H1N1 influenza necessitating admission to the ICU was associated with delayed initiation of antiviral therapy, history of opium inhalation, and some symptoms including; productive cough, hemoptysis, chest pain, confusion, and loss of consciousness.
A significant higher rate of opium addiction in ICU patients supports the idea that it could predispose patients to severe infection [Table 1]. So this risk factor could be more evaluated during the future pandemics.
As Frederick et al. believe delay in antiretroviral therapy is a risk factor for severe infection and mortality, the results confirmed that the idea, however, it was not significant due to small number of population study (7.42 ± 4.07 vs. 5.29 ± 3.68). [15]
Further investigation of respiratory specimens revealed 32.6% of patients had coinfection of seasonal influenza A and pandemic H1N1 virus. However, this finding has no significant relation with mortality. This finding should be considered during future potential pandemics. Despite these associations, the lack of a control group limits the ability to extrapolate from this observation. Further research and analysis is required for clarification of many complex and interrelated factors involved in the outcomes of pandemic H1N1 influenza.
| Acknowledgments | | |
We thank NRITLD for its generous support as well as the dedicated team of nurses and community health care workers at Masih Daneshvari Hospital, Tehran, Iran. The authors would like to thank Kimberly Field RN, MSN, from National Tuberculosis Controllers Association for her kind review of the manuscript and invaluable comments.
| References | | |
| 1. | Chan M. World now at start of 2009 influenza pandemic. World Health Organization. Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.Html. [cited in 2009 Jun]. 
|
| 2. | Novel swine-origin influenza A (H1N1) virus investigation team. Emergence of a novel swine-origin influenza in humans. N Engl J Med 2009; 360:2605-15.
|
| 3. | Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautistia E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-9.
|
| 4. | Gooya MM, Soroush M, Mokhtari-Azad T, Haghdoost AA, Hemati P, Moghadami M, et al. Influenza A (H1N1) pandemic in Iran: Report of first confirmed cases from June to November 2009. Arch Iran Med 2010; 13:91-8.
|
| 5. | ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-34.
|
| 6. | Intensive-care patients with severe novel influenza A (H1N1) virus infection: Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:749-52.
|
| 7. | Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, Kaewchana S, et al. Severe human influenza infections in Thailand: Oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4:e6051.
|
| 8. | Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.
|
| 9. | WHO.CDC protocol of real-time RT-PCR for swine influenza A (H1N1). Available from: http://www.who.int/csr/resources/nonepublications/swineflu /realtimeptpcr/en/index.html. [revised on 2009 Apr 28]
|
| 10. | Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2009; 84:481-4.
|
| 11. | Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-902.
|
| 12. | Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302:1880-7.
|
| 13. | The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34.
|
| 14. | Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-9.
|
| 15. | Hayden FG. Clinical aspects of pandemic 2009 influenza a (H1N1) virus infection. N Engl J Med 362; 18; 1708-19.
|
| 16. | Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339:b5213.
|
| 17. | Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181:72-9.
|
| 18. | Yazdanbakhsh M, Kremsner PG. Influenza in Africa. PLoS Med 2009; 6:e1000182.
|
[Table 1], [Table 2] |
|
| This article has been cited by | | 1 |
Combination therapy of IFNß1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients |
|
| Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani, Afshin Moniri, Zahra Abtahian, Somayeh Ghadimi, Melika Valizadeh, Jalal Heshmatnia, Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, Alireza Eslaminejad, Seyed MohammadReza Hashemian, Hamidreza Jamaati, Alireza Zali, Ali Akbar Velayati, Payam Tabarsi | | International Immunopharmacology. 2021; 92: 107329 | | [Pubmed] | [DOI] | | | 2 |
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic |
|
| Ali Farhoudian, Seyed Ramin Radfar, Hossein Mohaddes Ardabili, Parnian Rafei, Mohsen Ebrahimi, Arash Khojasteh Zonoozi, Cornelis A. J. De Jong, Mehrnoosh Vahidi, Masud Yunesian, Christos Kouimtsidis, Shalini Arunogiri, Helena Hansen, Kathleen T. Brady | | Frontiers in Psychiatry. 2021; 12 | | [Pubmed] | [DOI] | | | 3 |
Pharmacokinetic behavior of peramivir in the plasma and lungs of rats after trans-nasal aerosol inhalation and intravenous injection |
|
| Hao Ding, Siyang Wu, Xianhui Dai, Yang Gao, Ying Niu, Na Fang, Yang Song, Muzihe Zhang, Xiaoyang Wang, Tengfei Chen, Guangping Zhang, Jiarui Wu, Yingfei Li, Jin Han | | Biomedicine & Pharmacotherapy. 2020; 129: 110464 | | [Pubmed] | [DOI] | | | 4 |
Prognostic Factors and Analytical Abnormalities in Patients Admitted With the Diagnosis of Influenza in a Third Level Hospital During the 2015–2016 Season |
|
| Néstor Vázquez-Agra, Vanesa Alende-Castro, Cristina Macía-Rodriguez, Ana-Teresa Marques-Afonso, Martín Vidal-Vazquez, Vanesa Riveiro Blanco, Ignacio Novo-Veleiro | | Open Respiratory Archives. 2020; 2(1): 17 | | [Pubmed] | [DOI] | | | 5 |
Adverse event analysis in fatal cases of influenza A (H1N1) – A lesson from Poland |
|
| Tomasz Jurek,Marta Rorat | | Journal of Forensic and Legal Medicine. 2013; 20(8): 1131 | | [Pubmed] | [DOI] | | | 6 |
Risk factors for adult death due to 2009 pandemic influenza a (H1N1) virus infection: A 2151 severe and critical cases analysis |
|
| Zhang, P.-J. and Cao, B. and Li, X.-L. and Liang, L.-R. and Yang, S.-G. and Gu, L. and Xu, Z. and Hu, K. and Zhang, H.-Y. and Yan, X.-X. and Huang, W.-B. and Chen, W. and Zhang, J.-X. and Li, L.-J. and Wang, C. | | Chinese Medical Journal. 2013; 126(12): 2222-2228 | | [Pubmed] | | | 7 |
Morbidity and mortality associated to influenza A (H1N1) 2009 admissions in two hospitals of the Metropolitan area and analysis of its economic impact [Morbilidad y mortalidad asociada a hospitalizaciones por influenza pandémica A (H1N1) 2009 en dos hospitales de la región Metropolitana y evaluación de su impacto económico] |
|
| Armstrong, M. and Fica, A. and Dabanch, J. and Olivares, F. and Fasce, R. and Triantafilo, V. | | Revista Chilena de Infectologia. 2012; 29(6): 664-671 | | [Pubmed] | | | 8 |
Pandemic influenza A H1N1 in Iran and lessons learnt |
|
| Tavana, A. | | Annals of Tropical Medicine and Public Health. 2012; 5(4): 295-297 | | [Pubmed] | | | 9 |
IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated epstein-barr virus infection |
|
| Mansouri, D. and Mahdaviani, S.A. and Khalilzadeh, S. and Mohajerani, S.A. and Hasanzad, M. and Sadr, S. and Nadji, S.A. and Karimi, S. and Droodinia, A. and Rezaei, N. and Linka, R.M. and Bienemann, K. and Borkhardt, A. and Masjedi, M.R. and Velayati, A.A. | | International Archives of Allergy and Immunology. 2012; 158(4): 418-422 | | [Pubmed] | | | 10 |
Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 [Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, CrÃtica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente CrÃtico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y MicrobiologÃa clinica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1] |
|
| RodrÃguez, A. and álvarez-Rocha, L. and Sirvent, J.M. and Zaragoza, R. and Nieto, M. and Arenzana, A. and Luque, P. and SocÃas, L. and MartÃn, M. and Navarro, D. and Camarena, J. and Lorente, L. and Trefler, S. and Vidaur, L. and Solé-Violán, J. and Barcenilla, F. and Pobo, A. and Vallés, J. and Ferri, C. and MartÃn-Loeches, I. and DÃaz, E. and López, D. and López-Pueyo, M.J. and Gordo, F. and Del Nogal, F. and Marqués, A. and Tormo, S. and Fuset, M.P. and Pérez, F. and Bonastre, J. and Suberviola, B. and Navas, E. and León, C. | | Medicina Intensiva. 2012; 36(2): 103-137 | | [Pubmed] | | | 11 |
Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China |
|
| Zhang, P.-J. and Li, X.-L. and Cao, B. and Yang, S.-G. and Liang, L.-R. and Gu, L. and Xu, Z. and Hu, K. and Zhang, H.-Y. and Yan, X.-X. and Huang, W.-B. and Chen, W. and Zhang, J.-X. and Li, L.-J. and Wang, C. | | BMC Infectious Diseases. 2012; 12(29) | | [Pubmed] | | | 12 |
Characteristics of patients hospitalized with 2009 H1N1 influenza in a Tertiary Care Hospital in Southern Saudi Arabia |
|
| # Agha, A., Alrawi, A., Munayco, C.V., AlAyed, M.S., Al-Hakami, M., Korairi, H., Bella, A. | | # # Mediterranean Journal of Hematology and Infectious Diseases. 2012; 4(1): art-2012002 | | [Pubmed] | | | 13 |
Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Crítico (GEIPC) de la Sociedad Española de Enfermedades Infecciosas y Microbiología clínica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1 en pacientes adultos graves hospitalizados en las Unidades de Cuidados Intensivos |
|
| A. Rodríguez,L. Álvarez-Rocha,J.M. Sirvent,R. Zaragoza,M. Nieto,A. Arenzana,P. Luque,L. Socías,M. Martín,D. Navarro,J. Camarena,L. Lorente,S. Trefler,L. Vidaur,J. Solé-Violán,F. Barcenilla,A. Pobo,J. Vallés,C. Ferri,I. Martín-Loeches,E. Díaz,D. López,M.J. López-Pueyo,F. Gordo,F. del Nogal,A. Marqués,S. Tormo,M.P. Fuset,F. Pérez,J. Bonastre,B. Suberviola,E. Navas,C. León | | Medicina Intensiva. 2012; 36(2): 103 | | [Pubmed] | [DOI] | | | 14 |
Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit |
|
| A. Rodríguez,L. Álvarez-Rocha,J.M. Sirvent,R. Zaragoza,M. Nieto,A. Arenzana,P. Luque,L. Socías,M. Martín,D. Navarro,J. Camarena,L. Lorente,S. Trefler,L. Vidaur,J. Solé-Violán,F. Barcenilla,A. Pobo,J. Vallés,C. Ferri,I. Martín-Loeches,E. Díaz,D. López,M.J. López-Pueyo,F. Gordo,F. del Nogal,A. Marqués,S. Tormo,M.P. Fuset,F. Pérez,J. Bonastre,B. Suberviola,E. Navas,C. León | | Medicina Intensiva (English Edition). 2012; 36(2): 103 | | [Pubmed] | [DOI] | | | 15 |
Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China |
|
| Peng-jun Zhang,Xiao-li Li,Bin Cao,Shi-gui Yang,Li-rong Liang,Li Gu,Zhen Xu,Ke Hu,Hong-yuan Zhang,Xi-xin Yan,Wen-bao Huang,Wei Chen,Jing-xiao Zhang,Lan-juan Li,Chen Wang | | BMC Infectious Diseases. 2012; 12(1): 29 | | [Pubmed] | [DOI] | | | 16 |
Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome |
|
| Charles-Édouard Luyt,Alain Combes,Jean-Louis Trouillet,Ania Nieszkowska,Jean Chastre | | La Presse Médicale. 2011; 40(12): e561 | | [Pubmed] | [DOI] | | | 17 |
Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome |
|
| Luyt, C.-T., Combes, A., Trouillet, J.-L., Nieszkowska, A., Chastre, J. | | Presse Medicale. 2011; 40: 561-568 | | [Pubmed] | |
|
|
|
|
|
|
|
|
|
